Findings reference
Find a precise term among 2,612 objective findings.
Findings entries
Choose a page| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
tympanosclerosis | white scar-like or calcified plaques involving the eardrum or middle ear | Tympanosclerosis was visible as a focal plaque on the drum. | Objective | Ear, nasal and upper airway examinations |
tympanostomy tube patency | whether an ear ventilation tube is open | Tympanostomy tube patency was documented separately for the right and left ears. | Objective | Ear, nasal and upper airway examinations |
vocal fold mobility | movement of each vocal fold during breathing and voicing | Vocal fold mobility was assessed during flexible laryngoscopy. | Objective | Ear, nasal and upper airway examinations |
1,25-dihydroxyvitamin D | active vitamin D metabolite measured for a specific clinical question | 1,25-dihydroxyvitamin D was reviewed with kidney function and calcium balance. | Objective | Glucose monitoring, endocrine testing and urine studies |
25-hydroxyvitamin D | circulating vitamin D metabolite commonly used to assess vitamin D status | 25-hydroxyvitamin D was reported separately from the active vitamin D metabolite. | Objective | Glucose monitoring, endocrine testing and urine studies |
ACTH stimulation test | cortisol response measured before and after administration of synthetic ACTH | The ACTH stimulation test was reported with the assay and sampling schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
aldosterone-renin ratio | aldosterone concentration divided by a stated renin measure | The aldosterone-renin ratio was recorded with units, posture and relevant medicines. | Objective | Glucose monitoring, endocrine testing and urine studies |
C-peptide | peptide released with endogenous insulin and used to assess endogenous insulin production | C-peptide was interpreted with the paired glucose and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
capillary glucose | glucose measured in a capillary blood specimen | Capillary glucose was documented with time and relation to the meal. | Objective | Glucose monitoring, endocrine testing and urine studies |
coefficient of variation for glucose | glucose standard deviation expressed as a percentage of mean glucose | Coefficient of variation for glucose was calculated for the specified sensor-report period. | Objective | Glucose monitoring, endocrine testing and urine studies |
dexamethasone suppression test | assessment of cortisol suppression after a specified dexamethasone regimen | The dexamethasone suppression test was documented with dose timing and collection time. | Objective | Glucose monitoring, endocrine testing and urine studies |
documented symptomatic hypoglycemia | typical symptoms accompanied by a measured low glucose | Documented symptomatic hypoglycemia was recorded with the value, timing and response to treatment. | Objective | Glucose monitoring, endocrine testing and urine studies |
fasting glucose trend | pattern of glucose measurements obtained under fasting conditions | The fasting glucose trend was reviewed using the patient's dated log. | Objective | Glucose monitoring, endocrine testing and urine studies |
fractional excretion of sodium | fraction of filtered sodium excreted, estimated from paired urine and blood measurements | Fractional excretion of sodium was interpreted with recent diuretic use documented. | Objective | Glucose monitoring, endocrine testing and urine studies |
fractional excretion of urea | fraction of filtered urea excreted based on paired measurements | Fractional excretion of urea was reported with sample timing and the limitations of the estimate. | Objective | Glucose monitoring, endocrine testing and urine studies |
free thyroxine | unbound fraction of the thyroid hormone T4 | Free thyroxine was reported with the method-specific reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |
GAD65 antibody | antibody to glutamic acid decarboxylase 65 | The GAD65 antibody was documented with the testing indication and reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |
glucose management indicator | estimate derived from mean sensor glucose using the GMI equation | The glucose management indicator was recorded separately from measured hemoglobin A1c. | Objective | Glucose monitoring, endocrine testing and urine studies |
glucose nadir | lowest glucose value during the stated interval | Glucose nadir was identified in the overnight sensor record. | Objective | Glucose monitoring, endocrine testing and urine studies |
glucose rebound | rise in glucose following an earlier low value | Glucose rebound was documented alongside carbohydrate intake and treatment. | Objective | Glucose monitoring, endocrine testing and urine studies |
glucose trend arrow | device symbol indicating direction and rate category of glucose change | Glucose trend arrow was recorded at the time symptoms were reported. | Objective | Glucose monitoring, endocrine testing and urine studies |
glucosuria threshold | blood glucose concentration at which glucose begins appearing in urine under the stated conditions | The glucosuria threshold was discussed in light of the current medication. | Objective | Glucose monitoring, endocrine testing and urine studies |
glycated albumin | proportion of albumin modified by glucose | Glycated albumin was reviewed with the history of altered albumin turnover. | Objective | Glucose monitoring, endocrine testing and urine studies |
glycemic variability | degree of fluctuation in glucose across the observation period | Glycemic variability was reviewed with the mean and the monitoring duration. | Objective | Glucose monitoring, endocrine testing and urine studies |
hypoglycemia awareness | ability to perceive warning symptoms as glucose falls | Hypoglycemia awareness was assessed from recent episodes and glucose measurements. | Objective | Glucose monitoring, endocrine testing and urine studies |